Why the study?
Cardiovascular risk scores did not include cancer patients or oncological history, raising questions about their clinical applicability and how consecutive or simultaneous oncological therapies affect cardiovascular risk.
Answers are grounded in this paper and cite their sources.
The concept of 'cardiotoxicity memory' suggests that sequential cancer therapies have a cumulative impact on cardiovascular risk, necessitating comprehensive cardio-oncology risk assessment.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Andrés J. Daniele (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: